Today's racecards

Son in Galway Hurdle mix

Son Amix has an each-way chance if the weights stay down

Last Updated: 24/07/11 10:37am

  • Share:
Overturn would keep the weights down.

Overturn would keep the weights down.

Sky Bet

Tom Cooper is hoping that his Son Amix can finally enjoy his day in the sun in Thursday's Guinness Galway Hurdle where he also runs Total Excitement.

The French-bred grey has won only once since arriving from France but has run a number of fine races in defeat, filling the runner-up spot in the Pertemps Final at Cheltenham and, most recently, at the Punchestown Festival.

He is set to drop back to two miles in this week's fiercely competitive handicap, but his trainer does not expect that to be a problem.

Cooper said: "He's coming back to two miles but I wouldn't be concerned about that.

"A stiff two miles with all the hustle and bustle of the race should suit him.

"He handles all sorts of ground, but I think he's probably a better horse on better ground.

"I'm hoping Overturn comes over to keep the weights down and if he does I think our horse would have an each-way chance."

Outsider

Cooper is also set to saddle likely outsider Total Excitement, who ran well in good handicaps at Aintree and Punchestown in the spring.

"He normally runs a big race, although we were very disappointed with his last run in Killarney," Cooper added.

"It was an odd sort of run and we never really got to the bottom of it.

"The ground was a bit soft and he had a lot of weight.

"I think he's probably just a better horse with less weight on his back in a better race."

  • Share:

Related

Related Profiles

Most Popular

Features

Tip of the Day

Tip of the Day

Fancy a flutter on the racing? Let Sky Sports News' Alex Hammond mark your card every day.

Wednesday's preview

Wednesday's preview

Anita Chambers makes Water Hole her nap for Wednesday's racing - she has a tip for every UK and Irish race.

Racing Podcast

Racing Podcast

Our podcast team discuss all things racing including the Ayr Gold Cup and the recent Arc trials